57 results on '"Schnitzer, T."'
Search Results
2. POS0106 INTRA-ARTICULAR MM-II, A NOVEL SUSPENSION OF LARGE EMPTY MULTILAMELLAR LIPOSOMES, IN PAINFUL KNEE OSTEOARTHRITIS: A 26 WEEK PHASE 2B RANDOMIZED TRIAL
3. Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial
4. FRI0392 ADVERSE EVENTS IN PATIENTS WITH OSTEOARTHRITIS TREATED WITH SUBCUTANEOUS TANEZUMAB: A POOLED ANALYSIS OF THE OVERALL POPULATION AND SELECTED SUBGROUPS FROM 3 RANDOMISED PLACEBO-CONTROLLED TRIALS
5. FRI0378 GENERAL SAFETY AND TOLERABILITY OF SUBCUTANEOUS TANEZUMAB FOR THE TREATMENT OF OSTEOARTHRITIS: A POOLED ANALYSIS OF RANDOMIZED, PLACEBO-CONTROLLED TRIALS
6. OP0090 EFFICACY OF SUBCUTANEOUS TANEZUMAB FOR THE TREATMENT OF CHRONIC LOW BACK PAIN: AN ANALYSIS OF BRIEF PAIN INVENTORY-SHORT FORM SCORES FROM A 56-WEEK, RANDOMIZED, PLACEBO- AND TRAMADOL-CONTROLLED, PHASE 3 TRIAL
7. Comparison of Finite Volume and Discontinuous Galerkin Methods of Higher Order for Systems of Conservation Laws in Multiple Space Dimensions
8. Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip
9. Characterizing pain and relief after joint replacement in hip and knee osteoarthritis
10. SAT0575 Safety and efficacy of lutikizumab (ABT-981), an anti–interleukin-1 alpha/beta dual variable domain (DVD) immunoglobulin, in subjects with knee osteoarthritis: results from the randomised, double-blind, placebo-controlled, parallel-group phase 2 trial
11. Patency of vascular access ports in minipigs – A success story
12. LY2951742, a monoclonal antibody against CGRP, failed to reduce signs and symptoms of knee osteoarthritis
13. Applications of Bayesian statistical methodology to success criteria: A case study of a phase 2 design with interim futility assessment in patients with knee osteoarthritis
14. The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial
15. OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis
16. Viral Replication in Lymphocytes and the Pathogenesis of Connective Tissue Diseases
17. Dual energy X-ray absorptiometry of the knee in spinal cord injury: methodology and correlation with quantitative computed tomography
18. Characterization of osteoarthritis pain variability
19. Bone mineral and stiffness loss at the distal femur and proximal tibia in acute spinal cord injury
20. Bone mineral loss at the proximal femur in acute spinal cord injury
21. THE NITRIC OXIDE DONATOR NAPROXCINOD HAS BLOOD PRESSURE EFFECTS SIMILAR TO PLACEBO IN PATIENTS ON RENIN-ANGIOTENSIN SYSTEM BLOCKERS: 9D.02
22. EFFECTS OF THE CYCLOOXYGENASE INHIBITING NITRIC OXIDE DONATOR NAPROXCINOD VERSUS NAPROXEN AND IBUPROFEN ON 24-HOUR BP IN PATIENTS WITH OSTEOARTHRITIS AND HYPERTENSION: PP.33.295
23. Correlation of outcome measures and responder identification sensitivity in chronic low back pain: pooled analysis of 2 trials of etoricoxib
24. Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon–Schuss radiography
25. (214) Rofecoxib Provides Superior Relief of Pain in Osteoarthritis (OA) Compared to Celecoxib
26. Head-to-head comparison of the Lyon Schuss and fixed flexion radiographic techniques. Long-term reproducibility in normal knees and sensitivity to change in osteoarthritic knees
27. 267 COMPARISON OF EFFICACY OF LUMIRACOXIB 100 MG OD WITH CELECOXIB 200 MG OD IN THE OVERALL POPULATION AND AGE GROUPS <65 AND ≥65: COMBINED ANALYSIS OF TWO PIVOTAL STUDIES IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
28. 260 COMPARISON OF EFFICACY OF LUMIRACOXIB WITH CELECOXIB AND PLACEBO IN KNEE OSTEOARTHRITIS PATIENTS AND DIFFERING BASELINE DISEASE SEVERITY
29. 214 POSTER Characterization of a recombinant, fully human monoclonal antibody directed against the human insulin-like growth factor-1 receptor
30. Incidence of Nonvertebral Fractures in Relation to Time on Treatment and Bone Density in Glucocorticoid-Treated Patients
31. COX-2-selective inhibitors in the treatment of arthritis.
32. Hyperbolic Divergence Cleaning for the MHD Equations
33. (214) Rofecoxib Provides Superior Relief of Pain in Osteoarthritis (OA) Compared to Celecoxib
34. SAT0164 Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisis
35. Effect of Alendronate and MK-677 (a Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women1
36. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee
37. Knee pain and joint loading in subjects with osteoarthritis of the knee
38. Microemulsion formulation of cyclosporin (Sandimmun Neoral®) vs Sandimmun®: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis
39. CAMPATH-1H IN RHEUMATOID ARTHRITIS—AN INTRAVENOUS DOSE-RANGING STUDY
40. Severity of articular cartilage abnormality in patients with osteoarthritis: evaluation with fast spin-echo MR vs arthroscopy.
41. Simian Foamy Virus Pseudotypes of Vesicular Stomatitis Virus: Production and Use in Sero-epidemiological Investigations
42. MM subisoenzymes of creatine kinase as an index of disease activity in polymyositis.
43. Phenotypic Mixing between Two Primate Oncoviruses
44. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
45. Isolation and characterization of further defective clones of a temperature sensitive mutant (ts-1) of respiratory syncytial virus
46. Use of vesicular stomatitis virus pseudotypes to map viral receptor genes: Assignment of RD114 virus receptor gene to human chromosome 19
47. Phenotypic Mixing between Murine Oncoviruses and Murine Cytomegalovirus
48. Growth and genetic stability of the ts-1 mutant of respiratory syncytial virus at restrictive temperatures
49. Pseudotypes of vesicular stomatitis virus with the envelope properties of mammalian and primate retroviruses
50. Polymorphism of the Genomic RNAs Among the Avian Reoviruses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.